tradingkey.logo
搜尋

Integra Lifesciences Holdings Corp

IART
添加自選
18.050USD
+0.160+0.89%
收盤 07/02, 13:00美東報價延遲15分鐘
1.41B總市值
虧損本益比TTM

Integra Lifesciences Holdings Corp

18.050
+0.160+0.89%

關於 Integra Lifesciences Holdings Corp 公司

Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.

Integra Lifesciences Holdings Corp簡介

公司代碼IART
公司名稱Integra Lifesciences Holdings Corp
上市日期Aug 16, 1995
CEOPoul (Mojdeh)
員工數量4396
證券類型Ordinary Share
年結日Aug 16
公司地址1100 Campus Road
城市PRINCETON
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編08540
電話16092750500
網址https://www.integralife.com/
公司代碼IART
上市日期Aug 16, 1995
CEOPoul (Mojdeh)

Integra Lifesciences Holdings Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Ms. Mojdeh Poul
Ms. Mojdeh Poul
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
102.30K
--
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
--
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
88.25K
-1.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
50.49K
-16.02%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
35.42K
+38.07%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
34.65K
-3.31%
Dr. Stuart M. Essig, Ph.D.
Dr. Stuart M. Essig, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Robert T. Davis, Jr.
Mr. Robert T. Davis, Jr.
Executive Vice President, President - Tissue Technologies
Executive Vice President, President - Tissue Technologies
--
--
Ms. Barbara B. Hill
Ms. Barbara B. Hill
Independent Presiding Director
Independent Presiding Director
--
--
Mr. Eric I. Schwartz
Mr. Eric I. Schwartz
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Ms. Mojdeh Poul
Ms. Mojdeh Poul
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
102.30K
--
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
--
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
88.25K
-1.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
50.49K
-16.02%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
35.42K
+38.07%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
34.65K
-3.31%

常見問題

Integra Lifesciences Holdings Corp的前五大股東是誰?

Integra Lifesciences Holdings Corp的前五大股東如下:Ms. Mojdeh Poul

有多少機構持有Integra Lifesciences Holdings Corp(IART)的股份?

截至2026Q1,共有574家機構持有Integra Lifesciences Holdings Corp的股份,合計持有的股份價值約為82.80M,占公司總股份的106.43% 。與2025Q4相比,機構持股有所增加,增幅為-14508057.00。

哪個業務部門對Integra Lifesciences Holdings Corp的收入貢獻最大?

在2026Q1,Neurosurgery業務部門對Integra Lifesciences Holdings Corp的收入貢獻最大,創收827.67M,占總收入的50.61% 。